Cornelis H. Smit
Sneek, FR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Major human schistosome species express different glycans with immunological and diagnostic implications.
Journal: Nature communications
Published: July 11, 2025
How to Dose Vancomycin in Overweight and Obese Patients with Varying Renal (Dys)function in the Novel Era of AUC 400-600 mg·h/L-Targeted Dosing.
Journal: Clinical pharmacokinetics
Published: October 27, 2023
Vancomycin Clearance in Obese Adults is not Predictive of Clearance in Obese Adolescents.
Journal: Clinical pharmacokinetics
Published: February 13, 2023
Drug pharmacokinetics in the obese population: challenging common assumptions on predictors of obesity-related parameter changes.
Journal: Expert opinion on drug metabolism & toxicology
Published: October 11, 2022
Steering Away from Current Amoxicillin Dose Reductions in Hospitalized Patients with Impaired Kidney Function to Avoid Subtherapeutic Drug Exposure.
Journal: Antibiotics (Basel, Switzerland)
Published: June 29, 2022
Ciprofloxacin Pharmacokinetics After Oral and Intravenous Administration in (Morbidly) Obese and Non-obese Individuals: A Prospective Clinical Study.
Journal: Clinical pharmacokinetics
Published: April 12, 2022
Oral Ibuprofen Is More Effective than Intravenous Ibuprofen for Closure of a Patent Ductus Arteriosus: Can Pharmacokinetic Modeling Help Us to Understand Why?
Journal: Neonatology
Published: April 02, 2022
Optimizing moxidectin dosing for Strongyloides stercoralis infections: Insights from pharmacometric modeling.
Journal: Clinical and translational science
Published: June 23, 2021
Characterization of the Population Pharmacokinetics of Moxidectin in Adults Infected with Strongyloides Stercoralis: Support for a Fixed-Dose Treatment Regimen.
Journal: Clinical pharmacokinetics
Published: June 05, 2021
Dosing Recommendations for Vancomycin in Children and Adolescents with Varying Levels of Obesity and Renal Dysfunction: a Population Pharmacokinetic Study in 1892 Children Aged 1-18 Years.
Journal: The AAPS journal
Published: December 24, 2020
Novel strategy to personalise use of ibuprofen for closure of patent ductus arteriosus in preterm neonates.
Journal: Archives of disease in childhood
Published: December 08, 2020
Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties.
Journal: Clinical pharmacokinetics
Published: April 20, 2020
Last Updated: 09/26/2026